Blossom, great tips in general, but the GI's info about
LDN isn't right - actually, 67% of patients achieved remission while on LDN in the first clinical trial conducted by Penn State. This trial indicated LDN was effective for Crohn's, but the sample size of the trial was small (17 subjects), and a randomized placebo trial was needed, so further investigation continued, in a second clinical trial. Also, these patients seemed to continue to do well even after discontinuing LDN. Two of the subjects, who had fistulizing disease, responded to LDN, and the fistulas healed, though they did not respond to Infliximab.
The results were published in 2007 in the American Journal of Gastroenterology, and the title is "Low-Dose Naltrexone Therapy Improves Active Crohn's Disease." Even the title makes it clear LDN helps Crohn's. The article is well worth reading, because it painstakingly compares the costs/benefits of traditional meds to the costs/benefits of LDN.
The second clinical has been underway for some time, and was scheduled to end in the fall of this year.
Post Edited (njmom) : 12/8/2009 10:32:00 PM (GMT-7)